Dosimetry and first clinical evaluation of the new 18F-radiolabeled bombesin analogue BAY 864367 in patients with prostate cancer.
Sah BR, Burger IA, Schibli R, Friebe M, Dinkelborg L, Graham K, Borkowski S, Bacher-Stier C, Valencia R, Srinivasan A, Hany TF, Mu L, Wild PJ, Schaefer NG.
Sah BR, et al. Among authors: schibli r.
J Nucl Med. 2015 Mar;56(3):372-8. doi: 10.2967/jnumed.114.147116. Epub 2015 Feb 12.
J Nucl Med. 2015.
PMID: 25678494
Free article.